Inflammation of synovium is one of the hallmarks of rheumatoid arthritis (RA). Analysis of synovial tissue has increased our understanding of RA pathogenesis, aided in identifying potential therapeutic targets and has been used in the response and mechanistic evaluation of antirheumatic treatments. In addition, studies are ongoing, aimed at the identification of diagnostic and prognostic biomarkers in the synovium. This paper outlines the currently used procedures for sampling and processing of synovial tissue, and presents a standardised recommendation to support multicentre translational research.
Van De Sande, M. G. H., Gerlag, D. M., Lodde, B. M., Van Baarsen, L. G. M., Alivernini, S., Codullo, V., Felea, I., Vieira-Sousa, E., Fearon, U., Reece, R., Montecucco, C., Veale, D. J., Pitzalis, C., Emery, P., Klareskog, L., Mcinnes, I. B., Tak, P. P., Evaluating antirheumatic treatments using synovial biopsy: A recommendation for standardisation to be used in clinical trials, <<ANNALS OF THE RHEUMATIC DISEASES>>, 2011; 70 (3): 423-427. [doi:10.1136/ard.2010.139550] [http://hdl.handle.net/10807/114738]
Evaluating antirheumatic treatments using synovial biopsy: A recommendation for standardisation to be used in clinical trials
Alivernini, Stefano;
2011
Abstract
Inflammation of synovium is one of the hallmarks of rheumatoid arthritis (RA). Analysis of synovial tissue has increased our understanding of RA pathogenesis, aided in identifying potential therapeutic targets and has been used in the response and mechanistic evaluation of antirheumatic treatments. In addition, studies are ongoing, aimed at the identification of diagnostic and prognostic biomarkers in the synovium. This paper outlines the currently used procedures for sampling and processing of synovial tissue, and presents a standardised recommendation to support multicentre translational research.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
